ASX ANNOUNCEMENT TrivarX Limited (A.B.N. 58 008 130 336) Suite 1.01, 117 Camberwell Road, Hawthorn East VIC 3123 22 September 2026 Notice of Annual General Meeting and Closing Date for Director Nominations Perth, Australia: TrivarX Limited (‘the Company’) (ASX: TRI) advises that the...
TrivarX: Notice of AGM and Closing Date for Director Nominations
Filed with ASX · · 1 page · English
Summary by 6ix AI
TrivarX Limited has announced the details for its upcoming Annual General Meeting, scheduled for November. The company also specified the closing date for director nominations, which is at the end of September. This announcement is authorized by the Board of Directors of TrivarX Limited.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from TrivarX
- Appendix 4E - Preliminary Final Report
- June 2026 Quarterly Activities Report and Appendix 4C
- Stabl-Im clinical trial supply milestone achieved
- CRO Engaged to Advance Stabl-Im Phase 1 Trial
- March 2026 Quarterly Activities Report and Appendix 4C
Later from TrivarX
- Stabl-Im Clinical Development Update
- 2026 Annual Report
- Corporate Governance Statement
- Appendix 4G
- Notification of cessation of securities - TRI
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX